GSSC - ETF AI Analysis
Top Page
Goldman Sachs Activebeta U.S. Small Cap Equity ETF (GSSC)
Rating:64Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and over the past three months, showing solid recent momentum.
Broad Sector Diversification
Holdings are spread across many sectors, with meaningful weights in health care, financials, technology, and industrials, which helps reduce dependence on any single industry.
Low Expense Ratio
The fund’s relatively low expense ratio means investors keep more of the returns generated by the portfolio.
Negative Factors
Heavy U.S. Concentration
With the vast majority of assets in U.S. stocks, the ETF offers limited geographic diversification and is highly tied to the U.S. market.
Small-Cap Volatility Risk
Because the fund focuses on small-cap companies, investors should expect more price swings and sensitivity to changes in economic conditions.
Top Holdings Tilted to Health Care and Financials
Significant exposure to health care and financial stocks means the fund could be more affected if these sectors face a downturn.
GSSC vs. SPDR S&P 500 ETF (SPY)
AUM1.08B
RegionNorth America
Expense Ratio0.20%
Beta1.04
IssuerGoldman Sachs
Inception DateJun 28, 2017
Dividend Yield1.05%
Asset ClassEquity
Index TrackedGoldman Sachs ActiveBeta US Small Cap Equity
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume48,433
30 Day Avg. Volume34,059
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
107.33Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1411
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GSSC Summary
GSSC is an exchange-traded fund from Goldman Sachs that follows the Goldman Sachs ActiveBeta US Small Cap Equity index, focusing on smaller U.S. companies with room to grow. It spreads investments across many sectors like health care, financials, and technology, and holds names such as Alkermes and 10x Genomics. Investors might consider GSSC to add growth potential and diversification, since small-cap stocks can sometimes outperform larger, more established companies. However, small-cap stocks can be more volatile, so the value of this ETF can go up and down more sharply with the market.
How much will it cost me?The expense ratio for the Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) is 0.20%, which means you’ll pay $2 per year for every $1,000 invested. This is lower than average for actively managed ETFs, as they typically involve more research and strategy compared to passively managed funds.
What would affect this ETF?The Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) could benefit from economic growth and innovation in sectors like technology and health care, which are significant parts of its portfolio. However, small-cap companies are often more sensitive to rising interest rates, economic slowdowns, or regulatory changes, which could negatively impact their performance. Additionally, its U.S.-focused exposure means the ETF's performance is closely tied to domestic economic conditions.
GSSC Top 10 Holdings
GSSC is leaning heavily into U.S. small-cap health care and financial names, and that’s where most of the action is. Biotech players like 10x Genomics and CareDx have been rising sharply, giving the fund a strong tailwind, while Alkermes and Travere Therapeutics add more steady, if sometimes choppy, health care exposure. On the financial side, Enova and Dave have been climbing, helping offset mixed results from StoneX Group. With all holdings rooted in the U.S. and no single stock dominating, the story here is broad, high-octane small-cap growth rather than one star driving the show.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 1.00% | $10.77M | ― | ― | ― | |
| Enova International | 0.42% | $4.52M | $6.33B | 152.02% | 71 Outperform | |
| Alkermes | 0.39% | $4.22M | $8.22B | 85.96% | 80 Outperform | |
| CareDx | 0.38% | $4.13M | $2.26B | 279.76% | 77 Outperform | |
| 10x Genomics | 0.37% | $3.94M | $6.00B | 243.64% | 60 Neutral | |
| Dave | 0.33% | $3.56M | $4.74B | 62.58% | 80 Outperform | |
| StoneX Group | 0.32% | $3.49M | $9.10B | 74.52% | 58 Neutral | |
| Acadian Asset Management | 0.32% | $3.48M | $3.08B | 121.02% | 66 Neutral | |
| Travere Therapeutics | 0.31% | $3.32M | $5.20B | 244.49% | 56 Neutral | |
| ViaSat | 0.29% | $3.09M | $10.60B | 300.84% | 56 Neutral |
GSSC Technical Analysis
Positive
―
Price Trends
88.44
Positive
83.80
Positive
80.09
Positive
Market Momentum
0.30
Positive
57.74
Neutral
61.88
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GSSC, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 89.82, equal to the 50-day MA of 88.44, and equal to the 200-day MA of 80.09, indicating a bullish trend. The MACD of 0.30 indicates Positive momentum. The RSI at 57.74 is Neutral, neither overbought nor oversold. The STOCH value of 61.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GSSC.
GSSC Peer Comparison
Comparison Results
Performance Comparison
GSSC
Goldman Sachs Activebeta U.S. Small Cap Equity ETF
92.52
24.06
35.14%
FNDA
Schwab Fundamental US Small Co. Index ETF
―
―
―
FESM
Fidelity Enhanced Small Cap ETF
―
―
―
VIOO
Vanguard S&P Small-Cap 600 ETF
―
―
―
SMLF
iShares MSCI USA Small-Cap Multifactor ETF
―
―
―
CALF
Pacer US Small Cap Cash Cows 100 ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents